155 related articles for article (PubMed ID: 26492368)
1. Proteasomal inhibition sensitizes cervical cancer cells to mitomycin C-induced bystander effect: the role of tumor microenvironment.
Singh SV; Ajay AK; Mohammad N; Malvi P; Chaube B; Meena AS; Bhat MK
Cell Death Dis; 2015 Oct; 6(10):e1934. PubMed ID: 26492368
[TBL] [Abstract][Full Text] [Related]
2. Mitomycin C induces bystander killing in homogeneous and heterogeneous hepatoma cellular models.
Kumari R; Sharma A; Ajay AK; Bhat MK
Mol Cancer; 2009 Oct; 8():87. PubMed ID: 19845939
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
Hougardy BM; Maduro JH; van der Zee AG; de Groot DJ; van den Heuvel FA; de Vries EG; de Jong S
Int J Cancer; 2006 Apr; 118(8):1892-900. PubMed ID: 16287099
[TBL] [Abstract][Full Text] [Related]
4. Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells.
Kang YH; Lee KA; Ryu CJ; Lee HG; Lim JS; Park SN; Paik SG; Yoon DY
Cancer Lett; 2006 Jun; 237(1):33-44. PubMed ID: 16019139
[TBL] [Abstract][Full Text] [Related]
5. The apoptotic effect of intercalating agents on HPV-negative cervical cancer C-33A cells.
Kang YH; Lee KA; Yang Y; Kim SH; Kim JH; Park SN; Paik SG; Yoon DY
Amino Acids; 2007 Jul; 33(1):105-12. PubMed ID: 17021654
[TBL] [Abstract][Full Text] [Related]
6. [Study on the reversion of drug resistance in human cervical cancer cell lines].
Chen H; Chen H; Wu X
Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):669-71. PubMed ID: 11930693
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
[TBL] [Abstract][Full Text] [Related]
8. Bystander killing of breast cancer MCF-7 cells by MDA-MB-231 cells exposed to 5-fluorouracil is mediated via Fas.
Chhipa RR; Bhat MK
J Cell Biochem; 2007 May; 101(1):68-79. PubMed ID: 17340621
[TBL] [Abstract][Full Text] [Related]
9. Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines.
Miyamoto Y; Nakagawa S; Wada-Hiraike O; Seiki T; Tanikawa M; Hiraike H; Sone K; Nagasaka K; Oda K; Kawana K; Nakagawa K; Fujii T; Yano T; Kozuma S; Taketani Y
Oncol Rep; 2013 Jan; 29(1):51-7. PubMed ID: 23064281
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity and apoptosis enhancement in breast and cervical cancer cells upon coadministration of mitomycin C and essential oils in nanoemulsion formulations.
Al-Otaibi WA; Alkhatib MH; Wali AN
Biomed Pharmacother; 2018 Oct; 106():946-955. PubMed ID: 30119267
[TBL] [Abstract][Full Text] [Related]
11. Pre-existing Fas ligand (FasL) in cancer cells elicits tumor-specific protective immunity, but delayed induction of FasL expression after inoculation facilitates tumor formation.
Chiu HY; Sun GH; Chen SY; Wang HH; Ho MY; Chu CY; Wu WL; Jhou RS; Tsai YL; Huang RT; Sun KH; Tang SJ
Mol Carcinog; 2013 Sep; 52(9):705-14. PubMed ID: 22488710
[TBL] [Abstract][Full Text] [Related]
12. Antineoplastic activity of mitomycin C formulated in nanoemulsions-based essential oils on HeLa cervical cancer cells.
Alkhatib MH; Al-Otaibi WA; Wali AN
Chem Biol Interact; 2018 Aug; 291():72-80. PubMed ID: 29908166
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis of bladder cancer cells induced by short-term and low-dose Mitomycin-C: potential molecular mechanism and clinical implication.
Liu J; Wang Q; Wang X; Sun Y; Chen XY; Kong Q; Zhang KL; Li H
Int J Mol Med; 2003 Mar; 11(3):389-94. PubMed ID: 12579346
[TBL] [Abstract][Full Text] [Related]
14. A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.
Cao W; Li XQ; Wang X; Fan HT; Zhang XN; Hou Y; Liu SB; Mei QB
Phytomedicine; 2010 Jul; 17(8-9):598-605. PubMed ID: 20092988
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of recombinant human interleukin-6 on mouse bladder carcinoma through Fas-mediated apoptosis.
Li CG; Li ML; Shu XH; Liu YJ; Wu WS
Cancer Chemother Pharmacol; 2010 Oct; 66(5):981-6. PubMed ID: 20499068
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of berberine on human cervical carcinoma HeLa cells through mitochondria, death receptor and MAPK pathways, and in-silico drug-target prediction.
Lu B; Hu M; Liu K; Peng J
Toxicol In Vitro; 2010 Sep; 24(6):1482-90. PubMed ID: 20656010
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid.
Li Y; Xing D; Chen Q; Chen WR
Int J Cancer; 2010 Jul; 127(2):462-73. PubMed ID: 19908232
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha and interferon-gamma sensitize human tenon fibroblasts to mitomycin-C.
Wang XY; Crowston JG; Zoellner H; Healey PR
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3655-61. PubMed ID: 17652735
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin C modulates DNA-double strand break repair genes in cervical carcinoma cells.
Kang YH; Lee KA; Kim JH; Park SG; Yoon DY
Amino Acids; 2010 Nov; 39(5):1291-8. PubMed ID: 20352460
[TBL] [Abstract][Full Text] [Related]
20. Neferine Enhances the Antitumor Effect of Mitomycin-C in Hela Cells Through the Activation of p38-MAPK Pathway.
Eid W; Abdel-Rehim W
J Cell Biochem; 2017 Oct; 118(10):3472-3479. PubMed ID: 28328092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]